News

A new publication from Professor Martin Widschwendter and the EUTOPS team in the International Journal of Cancer describes the development of cervical cancer as a result of Human Papilloma Virus (HPV) infection.

The EUTOPS team presents four publications demonstrating that DNA methylation signature assessment using methylation array analysis in cervical screening samples detects and likely predicts the risk for all four major women’s cancers: breast, ovarian, womb and cervical cancer.

A new publication from Professor Martin Widschwendter and the EUTOPS team in Genome Medicine describes a new molecular test that can identify 55% of those with a normal cervical smear result who will go on to develop advanced cell changes or cancer within 4 years.

With the LIFE and SUN Tyrol studies, we are launching two large-scale investigations to test interval fasting, exercise and stress reduction for their health-promoting effects (LIFE Tyrol) and to optimize smoking cessation (SUN Tyrol).

Our paper describing a new test that accurately identifies women with womb cancer appears in Journal of Clinical Oncology today.

Our paper describing individualised breast cancer prevention and risk monitoring using antiprogestins and the epigenetic WID-Breast29 index appears in Genome Medicine today.

Today we published the WID epigenetic clocks (WID-age and WID-relative epithelial age, WID-REA) in Genome Biology.

Two new papers, assessing the risk for breast and ovarian cancer using the epigenetic footprint of cervical screening samples (WID Tests), are published in Nature Communications today.